• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性视网膜病变光凝治疗后与视力预后相关的因素。糖尿病性视网膜病变研究报告#13。

Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13.

作者信息

Kaufman S C, Ferris F L, Seigel D G, Davis M D, DeMets D L

机构信息

Biometry and Epidemiology Program, National Eye Institute, Bethesda, Maryland 20892.

出版信息

Invest Ophthalmol Vis Sci. 1989 Jan;30(1):23-8.

PMID:2912911
Abstract

Six risk factors for severe visual loss despite panretinal (scatter) photocoagulation were identified by analyzing data collected during the first 5 years after randomization in the Diabetic Retinopathy Study. Proportional hazards regression revealed NVD (neovascularization on/around the optic disc) to be the most important risk factor. The risk of severe visual loss rose with increasing NVD, hemorrhages/microaneurysms, retinal elevation, proteinuria, and hyperglycemia and fell with increasing "treatment density." These results are similar to previous DRS findings on untreated eyes. The importance of "treatment density" as an independent predictor of visual outcome is a new finding and lends support to the common clinical practice of repeating photocoagulation if initial treatment does not reduce or stabilize retinal neovascularization.

摘要

通过分析糖尿病视网膜病变研究随机分组后前5年收集的数据,确定了尽管进行了全视网膜(散射)光凝仍导致严重视力丧失的六个风险因素。比例风险回归显示视盘上/周围新生血管(NVD)是最重要的风险因素。严重视力丧失的风险随着NVD、出血/微动脉瘤、视网膜隆起、蛋白尿和高血糖的增加而上升,随着“治疗密度”的增加而下降。这些结果与糖尿病视网膜病变研究之前关于未治疗眼睛的发现相似。“治疗密度”作为视力结果独立预测因素的重要性是一项新发现,为初始治疗未能减少或稳定视网膜新生血管时重复进行光凝的常见临床实践提供了支持。

相似文献

1
Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13.糖尿病性视网膜病变光凝治疗后与视力预后相关的因素。糖尿病性视网膜病变研究报告#13。
Invest Ophthalmol Vis Sci. 1989 Jan;30(1):23-8.
2
Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10.
Invest Ophthalmol Vis Sci. 1985 Jul;26(7):983-91.
3
Management of proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的管理
Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56.
4
Xenon arc photocoagulation of proliferative diabetic retinopathy (a review of 2688 consecutive eyes in the format of the diabetic retinopathy study--DRS).增殖性糖尿病视网膜病变的氙弧光凝术(以糖尿病视网膜病变研究——DRS的形式对2688只连续眼进行的回顾)
Trans Am Ophthalmol Soc. 1983;81:229-45.
5
Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review.增殖性糖尿病视网膜病变成功进行散射激光光凝手术的视觉副作用:文献综述
Retina. 2007 Sep;27(7):816-24. doi: 10.1097/IAE.0b013e318042d32c.
6
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.后Tenon囊下注射曲安奈德可预防严重糖尿病视网膜病变且视力良好患者的全视网膜光凝所致视觉功能障碍。
Ophthalmology. 2006 Mar;113(3):381-7. doi: 10.1016/j.ophtha.2005.10.035. Epub 2006 Feb 3.
7
Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.重度糖尿病视网膜病变且视力良好的患者接受全视网膜光凝术后的视觉功能障碍
Am J Ophthalmol. 2005 Jul;140(1):8-15. doi: 10.1016/j.ajo.2005.02.029.
8
Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.糖尿病性视网膜病变玻璃体切除术后的视力预后以及光感和无光感视力的危险因素
Am J Ophthalmol. 2005 Aug;140(2):231-5. doi: 10.1016/j.ajo.2005.02.052.
9
Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5.增殖性糖尿病视网膜病变的光凝治疗:不良治疗效果与视网膜病变严重程度的关系。糖尿病视网膜病变研究报告第5号。
Dev Ophthalmol. 1981;2:248-61.
10
Photocoagulation in diabetic retinopathy. A multicentre study in Sweden.糖尿病性视网膜病变的光凝治疗。瑞典的一项多中心研究。
Acta Ophthalmol Suppl. 1984;162:1-100.

引用本文的文献

1
Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者全视网膜光凝术后的视觉诱发电位
Clin Ophthalmol. 2019 Aug 28;13:1635-1640. doi: 10.2147/OPTH.S213448. eCollection 2019.
2
Laser photocoagulation for proliferative diabetic retinopathy.增殖性糖尿病视网膜病变的激光光凝治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD011234. doi: 10.1002/14651858.CD011234.pub2.
3
Intravitreal bevacizumab as anti-vascular endothelial growth factor in the management of complications of proliferative diabetic retinopathy.
玻璃体内注射贝伐单抗作为抗血管内皮生长因子用于治疗增殖性糖尿病视网膜病变的并发症
Med Hypothesis Discov Innov Ophthalmol. 2013 Spring;2(1):20-4.
4
Diabetic retinopathy - An update.糖尿病视网膜病变——最新进展
Saudi J Ophthalmol. 2011 Apr;25(2):99-111. doi: 10.1016/j.sjopt.2011.01.009. Epub 2011 Jan 31.
5
Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy.分析糖尿病视网膜病变患者激光治疗不依从的原因。
Can J Ophthalmol. 2013 Apr;48(2):88-92. doi: 10.1016/j.jcjo.2012.09.012.
6
Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4.帕斯卡全视网膜激光光凝术和增生性糖尿病视网膜病变的回归分析:曼彻斯特帕斯卡研究报告 4。
Eye (Lond). 2011 Nov;25(11):1447-56. doi: 10.1038/eye.2011.188. Epub 2011 Aug 5.
7
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗糖尿病性视网膜病变:2010年格拉多夫讲座
J Ophthalmol. 2011;2011:584238. doi: 10.1155/2011/584238. Epub 2011 Mar 30.
8
Visually evoked potentials after panretinal photocoagulation in omani patients with uncontrolled diabetes mellitus.
Middle East Afr J Ophthalmol. 2008 Apr;15(2):51-6. doi: 10.4103/0974-9233.51992.
9
Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series.前房内注射贝伐单抗与丝裂霉素C小梁切除术治疗新生血管性青光眼:病例系列
J Ocul Biol Dis Infor. 2009 Mar 31;2(1):40-6. doi: 10.1007/s12177-009-9020-z.
10
Vitreous hemorrhage in diabetic eyes previously treated with panretinal photocoagulation.曾接受全视网膜光凝治疗的糖尿病性眼的玻璃体积血。
Int Ophthalmol. 2008 Feb;28(1):29-34. doi: 10.1007/s10792-007-9106-1. Epub 2007 Jul 10.